ABSCI CORP Interest Expense Nonoperating
ABSCI CORP (ABSI) reported Interest Expense Nonoperating of $2.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Expense Statement
us-gaap:InterestExpenseNonoperating · last filed 2026-08-11
- ABSCI CORP interest expense nonoperating for the quarter ending 2026-06-30 was $2.00K, a 96.43% decline year-over-year.
- ABSCI CORP interest expense nonoperating for the quarter ending 2026-03-31 was $18.00K, a 77.22% decline year-over-year.
- ABSCI CORP interest expense nonoperating for the quarter ending 2025-12-31 was $29.00K, a 73.39% decline year-over-year.
- ABSCI CORP interest expense nonoperating for the quarter ending 2025-09-30 was $45.00K, a 65.38% decline year-over-year.
- ABSCI CORP interest expense nonoperating for fiscal 2025 was $209.00K, a 63.01% decline from fiscal 2024.
- ABSCI CORP interest expense nonoperating for fiscal 2024 was $565.00K, a 44.06% decline from fiscal 2023.
- ABSCI CORP interest expense nonoperating for fiscal 2023 was $1.01M.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.00K 10-Q · filed 2026-08-11 | $20.00K 10-Q · filed 2026-08-11 | $49.00K derived: sum of 3 quarters · filed 2026-08-11 | $94.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | $18.00K 10-Q · filed 2026-05-07 | $47.00K derived: sum of 2 quarters · filed 2026-05-07 | $92.00K derived: sum of 3 quarters · filed 2026-05-07 | $148.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | $29.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $74.00K derived: sum of 2 quarters · filed 2026-03-24 | $130.00K derived: sum of 3 quarters · filed 2026-08-11 | $209.00K 10-K · filed 2026-03-24 |
| 2025-09-30 | $45.00K 10-Q · filed 2025-11-12 | $101.00K derived: sum of 2 quarters · filed 2026-08-11 | $180.00K 10-Q · filed 2025-11-12 | $289.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | $56.00K 10-Q · filed 2026-08-11 | $135.00K 10-Q · filed 2026-08-11 | $244.00K derived: sum of 3 quarters · filed 2026-08-11 | $374.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | $79.00K 10-Q · filed 2026-05-07 | $188.00K derived: sum of 2 quarters · filed 2026-05-07 | $318.00K derived: sum of 3 quarters · filed 2026-05-07 | $468.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $109.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $239.00K derived: sum of 2 quarters · filed 2026-03-24 | $389.00K derived: sum of 3 quarters · filed 2026-03-24 | $565.00K 10-K · filed 2026-03-24 |
| 2024-09-30 | $130.00K 10-Q · filed 2025-11-12 | $280.00K derived: sum of 2 quarters · filed 2025-11-12 | $456.00K 10-Q · filed 2025-11-12 | $660.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $150.00K 10-Q · filed 2025-08-12 | $326.00K 10-Q · filed 2025-08-12 | $530.00K derived: sum of 3 quarters · filed 2025-08-12 | $759.00K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $176.00K 10-Q · filed 2025-05-13 | $380.00K derived: sum of 2 quarters · filed 2025-05-13 | $609.00K derived: sum of 3 quarters · filed 2025-05-13 | $865.00K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $204.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $433.00K derived: sum of 2 quarters · filed 2025-03-18 | $689.00K derived: sum of 3 quarters · filed 2025-03-18 | $1.01M 10-K · filed 2025-03-18 |
| 2023-09-30 | $229.00K 10-Q · filed 2024-11-12 | $485.00K derived: sum of 2 quarters · filed 2024-11-12 | $806.00K 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $256.00K 10-Q · filed 2024-08-14 | $577.00K 10-Q · filed 2024-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |